César Serrano García, Group Leader of VHIO´s Sarcoma Translational Research Group, shared a post on X:
“Neoadjuvant chemotherapy and immunotherapy in sarcomas.
Select subtypes and stratify:
- Don’t focus only on ICIs – test new agents.
- Include pathological response as an endpoint.
- Use novel trial designs.
Wonderful overview from Maud Toulmonde at ESMO Rare Cancers 2025.”
